Silo Pharma, Inc. - Common Stock (SILO)
0.5302
+0.1744 (49.02%)
NASDAQ · Last Trade: Apr 7th, 11:15 PM EDT
Wondering what's happening in today's after-hours session?chartmill.com
Via Chartmill · April 7, 2026
Which stocks are most active on Tuesday?chartmill.com
Via Chartmill · April 7, 2026
On Tuesday, there are stocks with unusual volume. Let's take a look.chartmill.com
Via Chartmill · April 7, 2026
Which stocks are moving on Tuesday?chartmill.com
Via Chartmill · April 7, 2026
Gapping stocks in Tuesday's sessionchartmill.com
Via Chartmill · April 7, 2026
These stocks that are showing activity before the opening bell on Tuesday.chartmill.com
Via Chartmill · April 7, 2026
Curious about the stocks that are showing activity after the closing bell on Monday?chartmill.com
Via Chartmill · April 6, 2026
Curious about the stocks that are showing activity after the closing bell on Friday?chartmill.com
Via Chartmill · April 3, 2026
Which stocks are moving before the opening bell on Tuesday?chartmill.com
Via Chartmill · February 24, 2026
What's going on in today's after hours sessionchartmill.com
Via Chartmill · February 23, 2026
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · September 30, 2025
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · September 23, 2025
Silo Pharma partners with Fireblocks to secure its crypto treasury platform using multi-layer enterprise security and governance standards.
Via Benzinga · September 23, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · September 16, 2025
3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX.
Via MarketBeat · September 9, 2025
Hoth Therapeutics reported strong preclinical efficacy and safety data for HT-KIT, a precision antisense therapy targeting KIT-driven cancers.
Via Benzinga · September 2, 2025
Via Benzinga · August 19, 2025
Via Benzinga · June 9, 2025
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · June 9, 2025
U.S. stock futures were flat on Monday after closing higher on Friday. Futures of major benchmark indices were mixed in premarket.
Via Benzinga · June 9, 2025

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 5, 2025

Via Benzinga · June 5, 2025

